MethylPREDNISolone Acetate Injectable Suspension recall: Particulate Matter
MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT…
Why was MethylPREDNISolone Acetate Injectable Suspension recalled?
Presence of Particulate Matter: Potential for black particulates in the drug product.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots 5100186, 5100187, 5100188, 5100189, Exp 01/31/2025
- Product
- MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT…
- Recalling firm
- Sagent Pharmaceuticals
- Quantity
- 14,360 vials
- Distribution
- Nationwide in the USA
- Recall date
- May 22, 2024
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)